[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR100816264B1 - Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient - Google Patents

Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient Download PDF

Info

Publication number
KR100816264B1
KR100816264B1 KR1020060079161A KR20060079161A KR100816264B1 KR 100816264 B1 KR100816264 B1 KR 100816264B1 KR 1020060079161 A KR1020060079161 A KR 1020060079161A KR 20060079161 A KR20060079161 A KR 20060079161A KR 100816264 B1 KR100816264 B1 KR 100816264B1
Authority
KR
South Korea
Prior art keywords
extract
cosmetic composition
skin irritation
cosmetic
present
Prior art date
Application number
KR1020060079161A
Other languages
Korean (ko)
Other versions
KR20080017678A (en
Inventor
김성우
김형배
이건국
Original Assignee
주식회사 코리아나화장품
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코리아나화장품 filed Critical 주식회사 코리아나화장품
Priority to KR1020060079161A priority Critical patent/KR100816264B1/en
Publication of KR20080017678A publication Critical patent/KR20080017678A/en
Application granted granted Critical
Publication of KR100816264B1 publication Critical patent/KR100816264B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/044Suspensions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 목통 (Akebia quinata) 추출물을 유효 성분으로 포함하는 피부자극 완화용 화장료 조성물을 제공한다. 본 발명의 목통 추출물은 피부자극을 현저히 완화시켜 주고, 또한 증가된 항염증 활성을 갖으며, 화장료에 사용하였을 경우 탁월한 피부자극 완화 효과가 있어 화장품의 보조제로도 유용하다.The present invention is a neck ( Akebia It provides a cosmetic composition for alleviating skin irritation comprising a quinata extract as an active ingredient. The throat extract of the present invention significantly relieves skin irritation, has an increased anti-inflammatory activity, and when used in cosmetics, it has an excellent skin irritation relieving effect and is also useful as a cosmetic supplement.

목통 추출물, 피부자극 완화, 화장료 조성물, 보조제 Throat extract, skin irritation relief, cosmetic composition, supplement

Description

목통 추출물을 유효성분으로 함유하는 피부자극 완화용 화장료 조성물{Cosmetic Composition for Abirritating Skin Containing Extract of Akebia quinata as Active Ingredient}Cosmetic composition for relieving skin irritation containing neck extract as an active ingredient {Cosmetic Composition for Abirritating Skin Containing Extract of Akebia quinata as Active Ingredient}

본 발명은 피부자극 완화용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for skin irritation relief.

화장품은 피부를 청결히 하고 건강한 상태를 유지하며 미화를 위해 사용하는 것이나, 화장료 조성물에는 이와 같은 목적과는 상반되는 제품 제조 및 유지에 필수적인 성분들이 포함된다. 이들은 방부제, 계면활성제, 자외선 차단제, 미백제 등 화장료의 보존, 유지 및 기능을 부여하기 위하여 필수 불가결하게 첨가되는 성분들로 실제로 제품 사용시에 일부에서 피부 자극을 유발하기도 한다. 따라서, 화장품 제조업자들은 일반적으로 사용되는 자극 완화 물질을 제품에 적용시켜줌으로써 그 자극을 최소화시키기 위한 노력을 진행하고 있다.Cosmetics are used for cleansing, maintaining a healthy state and beautifying the skin, but the cosmetic composition includes ingredients necessary for the manufacture and maintenance of the product contrary to this purpose. These are ingredients that are indispensable for preserving, maintaining, and functioning cosmetics such as preservatives, surfactants, sunscreens, and whitening agents, and may cause skin irritation in some of the products actually used. Therefore, cosmetics manufacturers are making efforts to minimize the irritation by applying commonly used irritant substances to the product.

화장품의 사용에 의해 일어날 수 있는 피부 자극에는 가려움 (itching), 따끔거림 (stinging) 및 화끈거림 (burning)등의 자극감과 홍반 (erythema) 및 부종 (edema) 등이 있다. 이러한 자극들은 염증 반응의 현상으로 염증을 경감시키거나 제거시키는 작용을 하는 것을 항염제라 한다. 현재까지 항염의 목적으로 이용되고 있는 물질로는 비스테로이드계로서 플루페나믹산(flufenamic acid), 이부프로펜(ibuprofen), 벤지다민(benzydamine), 인도메타신(indometacine)등이 있고, 스테로이드 계통으로 프레드니솔론(prednisolone), 덱사메타손(dexamethasone) 등이 있으며(김창종, 병태생리학, 한림상사, p61-69, 1988), 알란토인, 아즈렌, ε-아미노키프론산, 하이드로코티존(v), 감초산 및 그 유도체(β-글리칠레친산, 글리칠레친산유도체) 등이 항염증에 효과가 있는 것으로 알려져 있으나(광정무부, 신화장품학, 남산당, p162, 1993), 인도메타신은 화장료에는 사용할 수 없는 물질이고 하이드로코티존은 사용량이 제한되어 있으며, 감초산 및 그 유도체는 안정화시키기 어렵거나 용해도가 좋지않아 실제 적용시 농도의 제한으로 인하여 실질적인 효과를 거두기가 어려운 문제점을 가지고 있다.Skin irritation that may occur with the use of cosmetics includes irritation such as itching, stinging and burning, and erythema and edema. These stimuli are called anti-inflammatory drugs that act to alleviate or eliminate inflammation as a phenomenon of the inflammatory response. To date, non-steroidal substances that are used for anti-inflammatory purposes include flufenamic acid, ibuprofen, benzydamine, indomethacin, and prednisolone as a steroid system. prednisolone) and dexamethasone (Kim Chang-jong, Pathophysiology, Hallym Co., p61-69, 1988), allantoin, azulene, ε-aminokiproic acid, hydrocortisone (v), licoriceic acid and its derivatives (β) -Glycylinic acid, Glychilechin acid derivatives, etc. are known to be effective in anti-inflammatory (Ministry of Justice, Department of New Cosmetics, Namsan Sugar, p162, 1993), but indomethacin cannot be used in cosmetics and hydrocortisone This is limited, licorice acid and its derivatives are difficult to stabilize or poor solubility is difficult to achieve a practical effect due to the limitation of concentration in actual application It has a point.

본 발명자들은 상기와 같은 단점을 보완하기 위하여 천연물을 대상으로 예의 연구를 수행한 결과 목통 추출물이 제형의 안정화가 쉽고 화장품에 의한 부작용을 줄이고 피부자극을 완화하는 효과를 갖는 물질임을 발견하여 본 발명을 완성하였다.The present inventors conducted a thorough study on natural products in order to compensate for the above disadvantages, and found that the neck extract is a substance having an effect of stabilizing the formulation, reducing side effects caused by cosmetics, and alleviating skin irritation. Completed.

따라서, 본 발명의 목적은 목통 추출물을 유효 성분으로 포함하는 피부자극 완화용 화장료 조성물을 제공하는 데 있다.Therefore, it is an object of the present invention to provide a cosmetic composition for skin irritation relief comprising the extract of the throat as an active ingredient.

본 발명의 다른 목적 및 이점은 하기의 실시예 및 청구범위에 의해 보다 명확하게 된다.Other objects and advantages of the present invention will become apparent from the following examples and claims.

본 발명의 다른 일 양태에 따르면, 본 발명은 목통 추출물을 유효 성분으로 포함하는 피부자극 완화용 화장료 조성물을 제공한다.According to another aspect of the present invention, the present invention provides a cosmetic composition for alleviating skin irritation, comprising a throat extract as an active ingredient.

본 발명의 유효 성분으로 이용된 목통은 으름덩굴과에 속하는 다년생 덩굴나무인 으름덩굴(Akebia quinata)의 줄기부분을 건조한 것으로 한의에서 소염약, 이뇨약, 진통약, 배농약으로 신장염, 심장병으로 인한 부기, 신경통, 관절염, 임신부기에 쓰인다. The barrel used as an active ingredient of the present invention is a perennial vine belonging to the ivy ( Akebia) quinata ) is a dry stem, used as an anti-inflammatory, diuretic, analgesic, and pear pesticide in oriental medicine. It is used for nephritis, heart disease, swelling, neuralgia, arthritis, and pregnancy.

상기 목통추출물은 다양한 추출 용매, 예를 들어, 물, 탄소수 1-4의 무수 또는 함수 저급 알코올 (메탄올, 에탄올, 프로판올 및 부탄올), 아세톤, 에틸 아세테이트, 클로로포름, 1,3-부틸렌글리콜 및 부틸 아세테이트로 구성된 군으로부터 선택되는 추출 용매로 하여 목통으로부터 얻을 수 있다. 보다 바람직하게는, 본 발명의 추출물은 함수 저급 알코올, 가장 바람직하게는 에탄올을 이용하여 얻어진 것이다. 한편, 본 발명의 추출물은 상기한 추출 용매 뿐만 아니라, 다른 추출 용매를 이용하여도 실질적으로 동일한 효과를 나타내는 추출물이 얻어질 수 있다는 것은 당업자에게 자명한 것이다.The neck extract can be a variety of extraction solvents, such as water, anhydrous or hydrous lower alcohols (methanol, ethanol, propanol and butanol) having 1 to 4 carbon atoms, acetone, ethyl acetate, chloroform, 1,3-butylene glycol and butyl It can be obtained from the barrel as an extraction solvent selected from the group consisting of acetate. More preferably, the extract of the present invention is obtained using a hydrous lower alcohol, most preferably ethanol. On the other hand, it will be apparent to those skilled in the art that the extract of the present invention can be obtained extracts having substantially the same effect using not only the above-described extraction solvent but also other extraction solvents.

또한, 본 발명의 추출물은 상술한 추출 용매에 의한 추출물 뿐만 아니라, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외 여과막을 이용한 분리, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 활성 분획도 본 발명의 추출물에 포함되는 것이다.In addition, the extract of the present invention includes not only the extract by the above-mentioned extraction solvent, but also the extract that has undergone a conventional purification process. Obtained by various additional purification methods, such as, for example, separation using an ultrafiltration membrane having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity). The active fraction is also included in the extract of the present invention.

본 발명의 바람직한 구현예에 따르면, 상기 추출물의 함량은 화장료 조성물 총 중량에 대하여 0.001-5.0 중량%이다. 상기 함량 미만일 경우에는 기대효과가 나타나기 어렵고, 상기 함량을 초과하는 경우에는 효과가 더 이상 증가하지 않는다.According to a preferred embodiment of the present invention, the content of the extract is 0.001-5.0% by weight relative to the total weight of the cosmetic composition. If the content is less than the expected effect is difficult to appear, if the content is exceeded the effect is no longer increased.

본 발명의 목통 추출물은 외부 물질에 의한 피부자극을 완화하고 항염증 활성이 있으며, 화장품 원료에 의한 피부자극을 완화한다. 따라서, 본 발명의 목통 추출물은 화장품 원료에 의한 피부자극을 완화하는 화장품 보조제로서 사용될 수 있다.Throat extract of the present invention to alleviate the skin irritation caused by external substances and has an anti-inflammatory activity, to mitigate the skin irritation caused by cosmetic raw materials. Therefore, the throat extract of the present invention can be used as a cosmetic supplement to alleviate skin irritation caused by cosmetic raw materials.

상기 화장료 조성물에서 피부자극을 일으키는 원료는 천연 추출물 및 화장료에 통상적으로 사용될 수 있는 성분을 포함한다. 피부자극을 일으키는 대표적인 원료로는 락틱산 (lactic acid), 글리콜릭산 (glycolic acid), 살리실산 (salicylic acid) 및 레티노산 (retinoic acid)이 있으나 이에 한정되는 것은 아니다. Raw material causing skin irritation in the cosmetic composition includes a natural extract and ingredients that can be commonly used in cosmetics. Representative raw materials that cause skin irritation include, but are not limited to, lactic acid, glycolic acid, salicylic acid and retinoic acid.

본 발명의 화장료 조성물은 목통 추출물을 유효 성분으로 포함하는 조성물로서 제조되어, 피부 자극성이 큰 화장료 조성물을 피부에 적용하기 전 또는 적용한 후에 적용될 수 있다. 또한, 목통 추출물을 피부 자극성이 큰 화장료 조성물에 추가적으로 첨가시켜 피부에 적용될 수도 있다.The cosmetic composition of the present invention is prepared as a composition comprising a neck extract as an active ingredient, and may be applied before or after applying the cosmetic composition having a large skin irritation to the skin. In addition, the extract may be applied to the skin by additionally added to the cosmetic composition having a high skin irritation.

본 발명의 화장품 조성물에 포함되는 성분은 유효 성분으로서 상기 목통 추출물 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The ingredients included in the cosmetic composition of the present invention include ingredients commonly used in cosmetic compositions in addition to the neck extract as an active ingredient, and include, for example, conventional auxiliaries such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings, And carriers.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.Cosmetic compositions of the present invention may be prepared in any formulation conventionally prepared in the art and include, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing , Oils, powder foundations, emulsion foundations, wax foundations and sprays, and the like, but are not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oils, vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide may be used as carrier components. Can be.

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, in particular in the case of a spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Soluble cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.

본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.

본 발명은 화장품을 피부에 도포하였을 때 발생할 수 있는 피부자극을 목통 추출물을 이용하여 완화시켜줌으로써 화장품의 피부 안전성을 증진시킨다.The present invention improves skin safety of cosmetics by relieving skin irritation that may occur when cosmetics are applied to the skin by using a throat extract.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it is to those of ordinary skill in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. Will be self-evident.

제조예 1. 목통 추출물의 제조Preparation Example 1 Preparation of Bark Extract

목통을 정제수로 세척한 후 건조하고 작은 조각으로 파쇄한 뒤, 여기에 그 건조 중량의 1-10배의 70% 저급알코올을 가하였다. 15-35℃에서 5일간 추출한 후 300메쉬 여과포로 여과하고, 다시 와트만 5번 여과지로 여과한 후, 회전 감압증발기로 건조하여, 건조 중량 63 g/㎏을 얻었다. 건조된 목통 추출 파우더를 30% 1,3-부틸렌 글리콜에 용해하여 사용하였다.The neck was washed with purified water and then dried and broken into small pieces, to which 70% lower alcohol, 1-10 times its dry weight, was added. The mixture was extracted at 15-35 ° C. for 5 days, filtered through a 300 mesh filter cloth, filtered through Whatman No. 5 filter paper, and then dried using a rotary evaporator to obtain a dry weight of 63 g / kg. The dried neck extract powder was used dissolved in 30% 1,3-butylene glycol.

실험예 1: 목통 추출물의 락틱산에 의한 세포자극의 완화 효과 시험Experimental Example 1 Test of the Relaxation Effect of Cellulose Extracts by Lactic Acid

인간 피부세포인 섬유아세포 (한국세포주은행)를 T-75 플라스크 (Falcon, 미합중국)에서 90%정도 성장할 때까지 배양하였다. 이것을 다시 96-웰 플레이트 (Falcon, 미합중국)에 3 × 104 세포/웰이 되게 옮겨 24시간 배양하였다. 배양 후 현미경을 통해 세포가 완전히 부착되어 잘 자라는지 여부를 확인하고 피부세포 자극원으로 락틱산을 이용하여 실험을 진행하였다. 이때 락틱산은 0.2% (이 농도에서 피부세포는 모두 사멸함)로 사용하였다. 즉, 96웰 플레이트의 각웰에 0.2% 락틱산이 함유된 DMEM (시그마, 미합중국) 배지를 200 ㎕씩 첨가하고 목통 추출물을 10, 20, 50, 100 및 200 ㎍/㎖로 조절하여 첨가하였다. 이때, 대조군에는 락틱산 및 추출물을 첨가하지 않았으며 비교군으로는 락틱산만 첨가한 것을 사용하였다. 시험 물질을 첨가하고 12시간 경과 후 세포의 생존율을 비교하기 위하여 MTT 시약을 각 웰에 10 ㎕씩 첨가하였다.Fibroblasts (Korea Cell Line Bank), which are human skin cells, were cultured in T-75 flasks (Falcon, USA) until 90% growth. This was again transferred to 96 × well plates (Falcon, USA) to 3 × 10 4 cells / well and incubated for 24 hours. After culturing, the microscope confirmed whether the cells were completely attached and grew well. The experiment was performed using lactic acid as a source of skin cell stimulation. At this time, lactic acid was used as 0.2% (all skin cells were killed at this concentration). That is, 200 μl of DMEM (Sigma, US) medium containing 0.2% lactic acid was added to each well of a 96 well plate, and the neck extract was adjusted to 10, 20, 50, 100 and 200 μg / ml. In this case, no lactic acid and extract were added to the control group, and only the lactic acid was added as a comparative group. Twelve μl of MTT reagent was added to each well to compare cell viability after 12 hours of addition of test material.

4시간 경과 후에 세포 생존율을 알아보기 위해, 엘라이저 리더(ELISA reader)를 이용하여 570 nm 파장에서 흡광도를 측정하고 하기 수학식 1에 따라 세포 생존율을 계산하고, 그 결과를 표 1에 기재하였다.In order to determine the cell viability after 4 hours, absorbance at 570 nm was measured using an ELISA reader, and cell viability was calculated according to Equation 1 below, and the results are shown in Table 1.

세포 생존율(%) = [(대조군 흡광도-시험 물질 흡광도)/대조군 흡광도] × 100Cell viability (%) = [(control absorbance-test material absorbance) / control absorbance] × 100

추출물의 농도 (㎍/㎖)Concentration of extract (µg / ml) 세포 생존율(%)Cell survival rate (%) 실험군Experimental group 비교군Comparison 대조군Control 1010 27.127.1 0.00.0 100.0100.0 2020 56.256.2 5050 83.483.4 100100 97.697.6 200200 103.5103.5

상기 표 1의 결과를 보면, 락틱산 처리된 세포에 목통 추출물을 처리한 경우 추출물 처리 농도 의존적으로 세포의 생존율이 증가하여, 락틱산에 의한 세포자극을 목통 추출물이 완화시켜 줌을 알 수 있었다.In the results of Table 1, it was found that when the neck extract was treated to the lactic acid treated cells, the survival rate of the cells increased depending on the concentration of the extract, and the neck extract was relieved of cell stimulation caused by the lactic acid.

실험예Experimental Example 2 : 목통 추출물의 항염증 효과 시험 2: anti-inflammatory effect test of neck extract

목통 추출물의 항염증 효과를 측정하기 위해서 평소 피부병 내지는 피부 알레르기 증상이 없는 사람 20명을 대상으로 항염증 효과를 측정하였다. 연령분포는 21-35세이고 평균연령은 29세였다. 시험방법은 다음과 같이 하였다. 팔 상박에 3군데 측정 위치를 표지한 후 chromameter로 피부의 홍반(a* value)을 측정하였다. 2군데 측정 위치에 5% 목통 추출물(실험군)과 감초산(비교군, 기존의 항염증제)을 각각 1시간 간격으로 4회 적용하고 나머지 한 군데(대조군)는 적용하지 않았다. 마지막 적용 20-30분 경과 후 측정 위치를 흐르는 물에 가볍게 닦아내었다.In order to measure the anti-inflammatory effect of the neck extract, the anti-inflammatory effect was measured in 20 people with no skin disease or skin allergy symptoms. The age distribution was 21-35 years old and the average age was 29 years old. The test method was as follows. After measuring three measurement locations on the upper arm, the erythema (a * value) of the skin was measured with a chromameter. 5% neck extract (experimental group) and licoriceic acid (comparative group, conventional anti-inflammatory agent) were applied 4 times at 1 hour intervals in two measurement locations, and the other one (control) was not applied. After 20-30 minutes of last application, the measurement site was lightly wiped with running water.

상박에 물이 다 마르면 3 mM 메틸 니코티메이트(methyl nicotimate, 0.04%)를 페이퍼 디스크에 80 ㎕를 덜어 흠뻑 적신 후 1분 30초 동안 올려 놓았다. 1분 30초 경과 후 페이퍼 디스크를 제거한 후 흐르는 물에 씻어 내었다. 20-30분 후 염증이 유발되면 홍반이 생기는데 이 홍반의 발생 정도를 chromameter로 측정하여 실험 초기의 홍반 정도와 비교하여 홍반 억제 정도를 평가하였다. 항염증 효과 평가는 하기 수학식 2와 같이 하여 그 결과를 표 2에 나타내었다.When the water was dried on the upper arm, 3 mM methyl nicotimate (0.04%) was soaked in 80 μl of paper disk, and placed for 1 minute and 30 seconds. After 1 minute and 30 seconds, the paper disk was removed and washed with running water. After 20-30 minutes of inflammation, erythema develops. The incidence of erythema is measured by chromatometer and the degree of erythema suppression is evaluated by comparing with erythema at the beginning of the experiment. Evaluation of the anti-inflammatory effect was performed as in Equation 2 below, and the results are shown in Table 2.

Figure 112006059598680-pat00001
Figure 112006059598680-pat00001

항염증 효과Anti-inflammatory effect 구분division △a*(처리후 - 처리전)Δa * (after treatment-before treatment) 홍반생성율(%)Erythema production rate (%) 항염증효과(%)Anti-inflammatory effect (%) 비처리(control)Control 1.541.54 100100 -- 5% 감초산5% licorice 1.181.18 73.373.3 26.726.7 5% 목통추출물5% neck extract 0.570.57 37.037.0 63.063.0

상기 표 2의 실험결과를 통해, 기존의 항염증제인 감초산에 비하여 본 발명의 목통 추출물의 항염증 효과가 훨씬 더 뛰어남을 알 수 있다.Through the experimental results of Table 2, it can be seen that the anti-inflammatory effect of the neck extract of the present invention is far superior to the conventional anti-inflammatory licorice.

상기 실험예를 근거로 피부자극 완화 효과가 우수한 목통 추출물을 함유하는 여러 가용화제형과 유화제형의 화장료 조성을 제시한다. 아래와 같은 제형예에서 이를 상세히 설명하지만 본 발명의 조성물이 하기 예에만 한정되는 것은 아니다.On the basis of the experimental example, it proposes a cosmetic composition of various solubilizing agent type and emulsifier type containing a throat extract excellent in skin irritation relief effect. Although this is described in detail in the following formulation example, the composition of the present invention is not limited only to the following examples.

제형예 1: 유연화장수 (스킨로션)Formulation Example 1: Softener (Skin Lotion)

하기의 표 3과 같이 목통 추출물을 함유하는 유연화장수를 통상의 방법에 따라 제조하였다.As shown in Table 3 below, the softening lotion containing the barrel extract was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 2.02.0 글리세린glycerin 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 3.03.0 PEG 1500PEG 1500 1.01.0 알란토인Allantoin 0.10.1 DL-판테놀DL-panthenol 0.30.3 EDTA-2NaEDTA-2Na 0.020.02 벤조페논-9Benzophenone-9 0.040.04 소듐 히아루로네이트Sodium hyaluronate 5.05.0 에탄올ethanol 10.010.0 옥틱도데세스-16Octicdodeceth-16 0.20.2 폴리솔베이트 20Polysorbate 20 0.20.2 incense 0.020.02 유니사이드-유 13Uniside-U 13 0.010.01 그린 #13Green # 13 0.0010.001 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 2. 수렴화장수Formulation Example 2. Converging Cosmetic Water

하기의 표 4와 같이 목통 추출물을 함유하는 수렴화장수를 통상의 방법에 따라 제조하였다.As shown in Table 4 below, astringent cosmetic water containing a throat extract was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 2.02.0 글리세린glycerin 2.02.0 1,3-부틸렌글리콜1,3-butylene glycol 2.02.0 알란토인Allantoin 0.20.2 DL-판테놀DL-panthenol 0.20.2 EDTA-2NaEDTA-2Na 0.020.02 벤조페논-9Benzophenone-9 0.040.04 소듐 히아루로네이트Sodium hyaluronate 3.03.0 에탄올ethanol 15.015.0 폴리솔베이트 20Polysorbate 20 0.30.3 위치하겔 추출물Witch Hagel Extract 2.02.0 구연산Citric acid 미량a very small amount incense 0.020.02 유니사이드-유 13Uniside-U 13 0.010.01 그린 #13Green # 13 0.0010.001 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 3. 영양화장수Formulation Example 3. Nutrients

하기의 표 5와 같이 목통 추출물을 함유하는 영양화장수를 통상의 방법에 따라 제조하였다.As shown in Table 5, nutritious longevity containing the neck extract was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 2.02.0 글리세릴 스테아레이트 SEGlyceryl Stearate SE 1.51.5 세테아릴알콜Cetearyl Alcohol 1.51.5 라놀린lanolin 1.51.5 폴리솔베이트 60Polysorbate 60 1.31.3 솔비탄스테아레이트Sorbitan stearate 0.50.5 경화식물유Cured Vegetable Oil 1.01.0 광물유Mineral oil 5.05.0 스쿠알란Squalane 3.03.0 트리옥타노인Trioctanoine 2.02.0 디메치콘Dimethicone 0.80.8 초산 토코페롤Tocopherol Acetate 0.50.5 카르복시비닐 폴리머Carboxyvinyl Polymer 0.120.12 글리세린glycerin 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 3.03.0 소듐히아루로네이트Sodium hyaluronate 5.05.0 트리에탄올아민Triethanolamine 0.120.12 incense 0.010.01 유니사이드-유 13Uniside-U 13 0.020.02 그린 #3Green # 3 0.0030.003 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 4. 영양크림Formulation Example 4. Nutrition Cream

하기의 표 6과 같이 목통 추출물을 함유하는 영양크림을 통상의 방법에 따라 제조하였다.Nutritious cream containing a throat extract as shown in Table 6 below was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 5.05.0 친유형 모노스테아린산글리세린Lipophilic monostearate 2.02.0 세테아릴알콜Cetearyl Alcohol 2.22.2 스테아린산Stearic acid 1.51.5 밀납Beeswax 1.01.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄스테아레이트Sorbitan stearate 0.60.6 경화식물유Cured Vegetable Oil 1.01.0 스쿠알란Squalane 3.03.0 광물유Mineral oil 5.05.0 트리옥타노인Trioctanoine 5.05.0 디메치콘Dimethicone 1.01.0 소듐마그네슘실리케이트Sodium magnesium silicate 0.10.1 글리세린glycerin 5.05.0 베타인Betaine 3.03.0 트리에탄올아민Triethanolamine 1.01.0 소듐히아루로네이트Sodium hyaluronate 4.04.0 incense 0.010.01 유니사이드-유13Uniside-Y13 0.020.02 그린 #3Green # 3 0.0030.003 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 5. 맛사지 크림Formulation Example 5. Massage Cream

하기의 표 7과 같이 목통 추출물을 함유하는 맛사지 크림을 통상의 방법에 따라 제조하였다.A massage cream containing a throat extract as shown in Table 7 below was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 4.04.0 친유형 모노스테아린산 글리세린Lipophilic Monostearic Acid Glycerin 1.51.5 세테아릴알콜Cetearyl Alcohol 1.51.5 스테아린산Stearic acid 1.01.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄스테아레이트Sorbitan stearate 0.60.6 이소스테아릴 이소스테레이트Isostearyl Isosterate 5.05.0 스쿠알란Squalane 5.05.0 광물유Mineral oil 35.035.0 디메치콘Dimethicone 0.50.5 히드록시에틸셀룰로오스Hydroxyethyl cellulose 0.120.12 글리세린glycerin 6.06.0 트리에탄올아민Triethanolamine 0.70.7 incense 0.010.01 유니사이드-유13Uniside-Y13 0.020.02 그린 #3Green # 3 0.0030.003 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 6. 에센스Formulation Example 6. Essence

하기의 표 8과 같이 목통 추출물을 함유하는 에센스를 통상의 방법에 따라 제조하였다.Essence containing the throat extract as shown in Table 8 below was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 4.04.0 글리세린glycerin 10.010.0 베타인Betaine 5.05.0 PEG 1500PEG 1500 2.02.0 알란토인Allantoin 0.10.1 DL-판테놀DL-panthenol 0.30.3 EDTA-2NaEDTA-2Na 0.020.02 벤조페논-9Benzophenone-9 0.040.04 히드록시에틸 셀룰로오스Hydroxyethyl cellulose 0.10.1 소듐 히아루로네이트Sodium hyaluronate 8.08.0 카르복시비닐폴리머Carboxy Vinyl Polymer 0.20.2 트리에탄올아민Triethanolamine 0.180.18 옥틸도데칸올Octyldodecanol 0.30.3 옥틸도데세스-16Octyldodeceth-16 0.40.4 에탄올ethanol 6.06.0 incense 0.020.02 유니사이드-유 13Uniside-U 13 0.010.01 그린 #3Green # 3 0.0010.001 증류수Distilled water 잔량Remaining amount 합계Sum 100100

제형예 7. 팩Formulation Example 7 Pack

하기의 표 9와 같이 목통 추출물을 함유하는 팩을 통상의 방법에 따라 제조하였다.As shown in Table 9 below, a pack containing a barrel extract was prepared according to a conventional method.

성분ingredient 함량 (중량%)Content (% by weight) 목통 추출물Throat extract 2.02.0 폴리비닐알콜Polyvinyl alcohol 15.015.0 셀룰로오스 검Cellulose gum 0.150.15 글리세린glycerin 3.03.0 PEG 1500PEG 1500 2.02.0 시이크데스트린Chicdestrin 0.150.15 DL-판테놀DL-panthenol 0.40.4 알란토인Allantoin 0.10.1 글리시리진산 모노암모늄Glycyrisin Monoammonium 0.30.3 니코틴아미드Nicotinamide 0.50.5 에탄올ethanol 6.06.0 PEG 40 경화피마자유PEG 40 Cured Castor Oil 0.30.3 incense 미량a very small amount 유니사이드-유13Uniside-Y13 0.020.02 그린 #3Green # 3 0.0030.003 증류수Distilled water 잔량Remaining amount 합계Sum 100100

실험예 3: 인체 피부 첩포시험Experimental Example 3: Human Skin Patch Test

과거력상 피부자극에 과민반응을 보인 적이 없으며, 현재 피부병 내지 피부 알러지 증상이 없는 20-30대 여성 20명을 대상으로 목통 추출물 5.0 중량%가 함유된 상기 제형예 4의 화장료에 피부 자극 물질인 락틱산 5.0 중량%를 자극원으로 첨가하여(실시예) 인체 피부 첩포시험을 통하여 자극 완화 효과를 확인하였다. 이 때 락틱산 및 목통 추출물을 첨가하지 않은 그룹을 대조군으로 하였고, 제형예 4의 화장료에 포함된 목통 추출물을 정제수로 대체하고 락틱산만 첨가한 것을 비교예 1로 하였으며, 제형예 4의 화장료에 포함된 목통 추출물을 5.0 중량% 감초산으로 대체한 것을 비교예 2로 하였다.Rock, which is a skin irritant in the cosmetic formulation of Formulation Example 4, containing 5.0 wt% of neck extract, targeting 20 women in their 20s and 30s who have never had hypersensitivity to skin irritation due to past history and have no skin disease or skin allergy symptoms. Tic acid 5.0% by weight was added as an irritant (Example), and the irritation-relieving effect was confirmed through a human skin patch test. At this time, the group without addition of the lactic acid and the throat extract was used as a control group, the neck extract included in the cosmetic formulation of Formulation Example 4 was replaced with purified water and only the lactic acid was added as Comparative Example 1, and included in the cosmetic formulation of Formulation Example 4 Comparative Example 2 was used to replace the neck extract extracted with 5.0% by weight licorice.

우선 시험부위를 70% 에탄올로 닦아낸 뒤 건조시켰다. 준비된 시험물질을 15 ㎍씩 핀 챔버 (Finn chamber, 100ㅧ10, EPITEST, 핀란드국) 내에 적하시킨 후 시험대상자의 전박 (forearm) 안쪽 부위에 밀폐첩포하였다. 24시간 동안 첩포하고 첩포를 제거한 후 표시펜으로 시험부위를 표시하였다. 각각 1시간 그리고 24시간 후(첩포 제거 후 1시간, 24시간 후 = 첩포 부착 포함 24시간, 48시간)에 확대경 (8MC-150, DAZOR, 미합중국)을 이용하여 시험 부위를 관찰하여 홍반 및 부종 유무를 관찰하였다.First the test site was wiped with 70% ethanol and dried. 15 μg of the prepared test substance was added dropwise into a Fin chamber (Finn chamber, 100 × 10, EPITEST, Finland), and then airtightly wrapped inside the forearm of the test subject. The patch was applied for 24 hours, the patch was removed, and the test site was marked with a marker pen. 1 hour and 24 hours after each removal (1 hour after removal, 24 hours = 24 hours, 48 hours including patch attachment) using a magnifying glass (8MC-150, DAZOR, United States) to observe the test site for erythema and edema Was observed.

피부반응은 국제접촉피부염연구회 (ICDRG: International Contact Dermatitis Research Group )의 규정에 따라 판정하였으며, 하기 수학식 3에 의하여 평균피부반응도를 계산하고 그 결과를 표 10에 나타내었다.The skin reaction was determined according to the regulations of the International Contact Dermatitis Research Group (ICDRG), and the average skin reactivity was calculated by Equation 3 below and the results are shown in Table 10.

※ 피부 반응의 평가 기준 및 점수 ※ Evaluation criteria and score of skin reaction

기 호Symbol 점 수score 평가 기준Evaluation standard -- 0 0 무반응, 정상 피부No response, normal skin ±± 0.5 0.5 희미한 또는 가벼운 홍반Faint or light erythema ++ 1.0 1.0 경계가 뚜렷하나 약한 홍반, 부종 및 구진Boundary but weak erythema, edema and papules ++++ 2.0 2.0 뚜렷한 홍반, 구진 및 소수포Pronounced erythema, papules and vesicles ++++++ 3.0 3.0 심한 홍반 및 소포형성Severe erythema and vesicle formation ++++++++ 6.0 6.0 대수포 형성Cannon formation

Figure 112006059598680-pat00002
Figure 112006059598680-pat00002

인체 피부 첩포시험 결과Human skin patch test result 시험물질Test substance 24시간24 hours 48시간48 hours 평균피부반응도 (n=20)Average skin reactivity (n = 20) ± + ++± + ++ ± + ++± + ++ 대조군Control 2 - -2 - - - - ---- 0.410.41 비교예 1Comparative Example 1 13 3 -13 3- 3 2 -3 2- 5.415.41 비교예 2Comparative Example 2 9 2 -9 2- 3 1 -3 1- 3.753.75 실시예Example 4 2 -4 2- 1 - -One - - 1.871.87

상기 표 10의 결과에서 알 수 있듯이, 5.0 중량%의 목통 추출물을 함유하는 실시예는 5.0 중량% 감초산을 함유한 비교예 2에 비해, 락틱산에 의해 유발된 피부자극의 완화 효과가 월등히 우수함을 알 수 있었다.As can be seen from the results of Table 10, the example containing 5.0% by weight of the neck extract is significantly superior to the relaxation effect of the skin irritation induced by lactic acid, compared to Comparative Example 2 containing 5.0% by weight licorice And it was found.

실험예 4 : 목통 추출물을 함유하는 크림의 제형의 안정성 시험Experimental Example 4: Stability test of the formulation of the cream containing the throat extract

본 발명의 화장료 제형의 온도 변화에 따른 안정성을 시험하였다. 목통 추출물을 함유한 상기 제형예 4의 영양크림, 제형예 4에서 목통 추출물을 5.0 중량% 감초산으로 대체한 크림(비교예), 그리고 정제수로 대체한 크림(대조예)을 불투명 초자 용기에 담아 45℃로 일정하게 유지되는 항온조에서 1주 동안 보관하고, 또한 불투명 초자 용기에 담아 4℃로 일정하게 유지되고 완전히 차광 된 냉장고 내에서 1주 동안 보관한 후 변색 정도를 비교 측정하였다. 그 결과는 하기 표 11에 나타나 있다. 이때 제품 변색 정도는 다음의 6등급으로 분류하여 평가하였다.The stability according to the temperature change of the cosmetic formulation of the present invention was tested. Nourishing cream of Formulation Example 4 containing the throat extract, cream (Comparative Example) replacing the neck extract with 5.0 wt% licorice in Formulation Example 4, and the cream (control) replaced with purified water in an opaque glass container After storage for 1 week in a constant temperature bath maintained at 45 ℃, and also kept in a opaque glass jar at a constant 4 ℃ and stored in a completely shaded refrigerator for 1 week, the degree of discoloration was measured. The results are shown in Table 11 below. At this time, the degree of product discoloration was evaluated by classifying into the following six grades.

※ 제품 변색 평가 기준※ criteria for evaluation of product discoloration

점 수score 평가 기준Evaluation standard 00 변화 없음 No change 1One 극히 조금 변함 Very little change 22 조금 변함 Little change 33 조금 심하게 변함 Slightly worse 44 심하게 변함 Badly changed 55 극히 심하게 변함 Extremely severe

제형의 안전성 시험 결과Safety test results of the formulation 온도Temperature 실험물질 변색 정도Discoloration degree of test substance 제형예 4Formulation Example 4 대조예Control 비교예Comparative example 45℃45 ℃ 00 00 44 4℃4 ℃ 00 00 22

상기 표 11의 결과에서 알 수 있는 바와 같이, 목통 추출물 대신 감초산을 함유한 비교예의 크림은 제형의 안정성이 미약하였지만, 목통 추출물을 함유하는 제형예 4의 크림은 변색이 거의 되지 않아 기존의 화장료에 비해 안정성이 매우 우수함을 알 수 있었다. 목통 추출물을 정제수로 대체한 대조예에서는 변색이 일어나지 않은 것으로 보아 크림의 기타 함유 성분에 의해서는 변색이 일어나지 않는다는 것을 알 수 있었다.As can be seen from the results of Table 11, the cream of Comparative Example containing licorice acid instead of the neck extract was weak in the stability of the formulation, the cream of Formulation Example 4 containing the neck extract is hardly discolored, the conventional cosmetics Compared to the stability was found to be very excellent. Discoloration did not occur in the control case where the neck extract was replaced with purified water, indicating that discoloration did not occur by the other ingredients of the cream.

이상에서 상세히 설명하듯이, 본 발명은 목통 추출물을 유효 성분으로 포함하는 피부자극 완화용 화장료 조성물을 제공한다. 본 발명의 목통 추출물은 기존 항염제에 비해 화장품 원료에 의한 피부자극을 현저히 완화시켜 주며, 또한 증가된 항염증 활성을 나타내므로, 화장료에 사용하였을 경우 탁월한 피부자극 완화 효과가 있다. 따라서, 본 발명의 화장료 조성물은 화장품을 피부에 도포하였을 때 발생할 수 있는 피부자극을 목통 추출물을 이용하여 완화시켜줄 수 있기 때문에 화장품의 피부 안전성을 증진시킬 수 있다.As described in detail above, the present invention provides a cosmetic composition for alleviating skin irritation, comprising a throat extract as an active ingredient. The neck extract of the present invention significantly relieves skin irritation by cosmetic raw materials, and also shows an increased anti-inflammatory activity, compared to existing anti-inflammatory agents, and when used in cosmetics, has an excellent skin irritation relief effect. Therefore, the cosmetic composition of the present invention can enhance skin safety of the cosmetic because it can relieve skin irritation that may occur when the cosmetic is applied to the skin by using a neck extract.

이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.Having described the specific part of the present invention in detail, it is apparent to those skilled in the art that the specific technology is merely a preferred embodiment, and the scope of the present invention is not limited thereto. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.

Claims (5)

목통 추출물(Akebia quinata)을 유효성분으로 함유하는 피부자극 완화용 화장료 조성물. Throat Extract ( Akebia Cosmetic composition for skin irritation relief containing quinata ) as an active ingredient. 제 1 항에 있어서, 상기 목통 추출물은 물, 탄소수 1-4의 무수 또는 함수 저급 알코올 (메탄올, 에탄올, 프로판올 또는 부탄올), 아세톤, 에틸 아세테이트, 클로로포름, 1,3-부틸렌글리콜 및 부틸 아세테이트로 구성된 군으로부터 선택되는 용매를 사용하여 추출된 것을 특징으로 하는 화장료 조성물.The method of claim 1, wherein the barrel extract is water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, propanol or butanol), acetone, ethyl acetate, chloroform, 1,3-butylene glycol and butyl acetate Cosmetic composition, characterized in that extracted using a solvent selected from the group consisting of. 삭제delete 제 1 항에 있어서, 상기 목통 추출물은 화장료 총중량에 대하여 0.001-5.0 중량%의 양으로 함유되는 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the throat extract is contained in an amount of 0.001-5.0% by weight based on the total weight of the cosmetic. 제 1 항에 있어서, 상기 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 제형을 갖는 것을 특징으로 하는 화장료 조성물.The composition of claim 1 wherein the cosmetic composition consists of a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation and spray Cosmetic composition, characterized in that it has a formulation selected from the group.
KR1020060079161A 2006-08-22 2006-08-22 Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient KR100816264B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060079161A KR100816264B1 (en) 2006-08-22 2006-08-22 Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060079161A KR100816264B1 (en) 2006-08-22 2006-08-22 Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient

Publications (2)

Publication Number Publication Date
KR20080017678A KR20080017678A (en) 2008-02-27
KR100816264B1 true KR100816264B1 (en) 2008-03-27

Family

ID=39384958

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060079161A KR100816264B1 (en) 2006-08-22 2006-08-22 Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient

Country Status (1)

Country Link
KR (1) KR100816264B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003057A (en) 2015-06-30 2017-01-09 재단법인 진안홍삼연구소 A composition comprising akebia quinata extract for preventing, improving or treating inflammation induced virulence of oral bacteria

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001335458A (en) * 2000-05-29 2001-12-04 Shiseido Co Ltd Skin care preparation
JP2001342112A (en) * 2000-06-02 2001-12-11 Shiseido Co Ltd Skin care preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001335458A (en) * 2000-05-29 2001-12-04 Shiseido Co Ltd Skin care preparation
JP2001342112A (en) * 2000-06-02 2001-12-11 Shiseido Co Ltd Skin care preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003057A (en) 2015-06-30 2017-01-09 재단법인 진안홍삼연구소 A composition comprising akebia quinata extract for preventing, improving or treating inflammation induced virulence of oral bacteria

Also Published As

Publication number Publication date
KR20080017678A (en) 2008-02-27

Similar Documents

Publication Publication Date Title
KR100844275B1 (en) Skin anti-aging cosmetic composition containing noni extract as an active ingredient
KR100501399B1 (en) Cosmetic Compostion for Preventing Skin Aging Comprising Plant Extract as Oriental Medicine Stabilized in Nanoliposome
KR20140012456A (en) Composition for improving skin conditions comprising akebia saponin d
KR20050122074A (en) Cosmetic composition comprising torreya nucifera extract as active ingredient for improving skin wrinkle and elasticity
KR100955572B1 (en) Cosmetic composition containing noni supercritical extract
KR101668029B1 (en) Cosmetic Composition for Reducing Skin Wrinkle Comprising Lapachol
KR100858628B1 (en) Cosmetic composition for skin stimulation alleviation comprising soruja extract stabilized with nano liposomes
KR20080093500A (en) Roe deer urine extract
KR20050071730A (en) Cosmetic compostion for alleviating skin irritation comprising mung bean extract stabilized in nanoliposome
KR100816264B1 (en) Cosmetic composition for alleviating skin irritation containing throat extract as an active ingredient
KR100816265B1 (en) Cosmetic composition for alleviating skin irritation containing rhubarb extract as an active ingredient
KR100638053B1 (en) Cosmetic composition for alleviating skin irritation containing Soru-Jin extract as an active ingredient
KR20100132206A (en) Cosmetic composition for improving the appearance of skin comprising ginsenoside Rh2 as an active ingredient
KR102181893B1 (en) Cosmetic and pharmaceutical compositin comprising aloe extract, upland rice extract and ceramide
KR20080046793A (en) Cosmetic composition for improving skin wrinkles containing longan extract as an active ingredient
KR20050120880A (en) Cosmetic composition having skin-irritation reducing effect and containing morinda citrifolia extract
KR100946584B1 (en) Cosmetic composition for astringent and skin irritation containing fruit extract and Blue Lotus extract
KR20200073523A (en) Cosmetic Composition for Improving Skin Wrinkle Contaning the Extract of Lithospermum Erythrorhizon
KR102470781B1 (en) Cosmetic Composition for Reducing Skin Wrinkle
KR20080057414A (en) Cosmetic composition for alleviating skin irritation containing azalea root extract
KR100635782B1 (en) Cosmetic composition for skin irritation relaxation containing peeled black bean extract as an active ingredient
KR100928125B1 (en) Wrinkle improvement cosmetic composition containing metasequoia extract
KR100537914B1 (en) Cosmetic Composition Comprising Calyx Kaki as Active Ingredient for Improving Skin Wrinkle and Elasticity
KR20090073632A (en) Cosmetic composition for alleviating skin irritation containing Yeok wood extract and licorice extract
KR20180096094A (en) A composition for improving skin wrinkle comprising Cosmos bipinnatus extract

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20060822

PA0201 Request for examination
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070720

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20080108

PG1501 Laying open of application
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20080318

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20080318

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20100902

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110916

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20130111

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20131127

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20131127

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20150112

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20150112

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20151211

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20151211

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20161227

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20161227

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20190109

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20190109

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20191226

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20191226

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20201222

Start annual number: 14

End annual number: 14

PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20221229